380 related articles for article (PubMed ID: 26980767)
1. TGFβ Signaling in the Pancreatic Tumor Microenvironment Promotes Fibrosis and Immune Evasion to Facilitate Tumorigenesis.
Principe DR; DeCant B; Mascariñas E; Wayne EA; Diaz AM; Akagi N; Hwang R; Pasche B; Dawson DW; Fang D; Bentrem DJ; Munshi HG; Jung B; Grippo PJ
Cancer Res; 2016 May; 76(9):2525-39. PubMed ID: 26980767
[TBL] [Abstract][Full Text] [Related]
2. TGFβ engages MEK/ERK to differentially regulate benign and malignant pancreas cell function.
Principe DR; Diaz AM; Torres C; Mangan RJ; DeCant B; McKinney R; Tsao MS; Lowy A; Munshi HG; Jung B; Grippo PJ
Oncogene; 2017 Jul; 36(30):4336-4348. PubMed ID: 28368414
[TBL] [Abstract][Full Text] [Related]
3. PEDF inhibits pancreatic tumorigenesis by attenuating the fibro-inflammatory reaction.
Principe DR; DeCant B; Diaz AM; Mangan RJ; Hwang R; Lowy A; Shetuni BB; Sreekumar BK; Chung C; Bentrem DJ; Munshi HG; Jung B; Grippo PJ; Bishehsari F
Oncotarget; 2016 May; 7(19):28218-34. PubMed ID: 27058416
[TBL] [Abstract][Full Text] [Related]
4. TGFβ Signaling Intersects with CD103 Integrin Signaling to Promote T-Lymphocyte Accumulation and Antitumor Activity in the Lung Tumor Microenvironment.
Boutet M; Gauthier L; Leclerc M; Gros G; de Montpreville V; Théret N; Donnadieu E; Mami-Chouaib F
Cancer Res; 2016 Apr; 76(7):1757-69. PubMed ID: 26921343
[TBL] [Abstract][Full Text] [Related]
5. TGFβ-derived immune modulatory vaccine: targeting the immunosuppressive and fibrotic tumor microenvironment in a murine model of pancreatic cancer.
Perez-Penco M; Weis-Banke SE; Schina A; Siersbæk M; Hübbe ML; Jørgensen MA; Lecoq I; Lara de la Torre L; Bendtsen SK; Martinenaite E; Holmström MO; Madsen DH; Donia M; Ødum N; Grøntved L; Andersen MH
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36600556
[TBL] [Abstract][Full Text] [Related]
6. Loss of TGFβ signaling promotes colon cancer progression and tumor-associated inflammation.
Principe DR; DeCant B; Staudacher J; Vitello D; Mangan RJ; Wayne EA; Mascariñas E; Diaz AM; Bauer J; McKinney RD; Khazaie K; Pasche B; Dawson DW; Munshi HG; Grippo PJ; Jung B
Oncotarget; 2017 Jan; 8(3):3826-3839. PubMed ID: 27270652
[TBL] [Abstract][Full Text] [Related]
7. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
[TBL] [Abstract][Full Text] [Related]
8. TGFβ Signaling in the Tumor Microenvironment.
Goulet CR; Pouliot F
Adv Exp Med Biol; 2021; 1270():89-105. PubMed ID: 33123995
[TBL] [Abstract][Full Text] [Related]
9. Surface Expression of TGFβ Docking Receptor GARP Promotes Oncogenesis and Immune Tolerance in Breast Cancer.
Metelli A; Wu BX; Fugle CW; Rachidi S; Sun S; Zhang Y; Wu J; Tomlinson S; Howe PH; Yang Y; Garrett-Mayer E; Liu B; Li Z
Cancer Res; 2016 Dec; 76(24):7106-7117. PubMed ID: 27913437
[TBL] [Abstract][Full Text] [Related]
10. Negative control of TRAIL-R1 signaling by transforming growth factor β1 in pancreatic tumor cells involves Smad-dependent down regulation of TRAIL-R1.
Radke DI; Ungefroren H; Helm O; Voigt S; Alp G; Braun H; Hübner S; Dilchert J; Sebens S; Adam D; Kalthoff H; Trauzold A
Cell Signal; 2016 Nov; 28(11):1652-62. PubMed ID: 27492861
[TBL] [Abstract][Full Text] [Related]
11. TGFβ Blockade Augments PD-1 Inhibition to Promote T-Cell-Mediated Regression of Pancreatic Cancer.
Principe DR; Park A; Dorman MJ; Kumar S; Viswakarma N; Rubin J; Torres C; McKinney R; Munshi HG; Grippo PJ; Rana A
Mol Cancer Ther; 2019 Mar; 18(3):613-620. PubMed ID: 30587556
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of TGFβ receptor II signalling in pancreatic epithelial cells promotes acinar cell proliferation, acinar-to-ductal metaplasia and fibrosis during pancreatitis.
Grabliauskaite K; Saponara E; Reding T; Bombardo M; Seleznik GM; Malagola E; Zabel A; Faso C; Sonda S; Graf R
J Pathol; 2016 Feb; 238(3):434-45. PubMed ID: 26510396
[TBL] [Abstract][Full Text] [Related]
13. Neutralizing murine TGFβR2 promotes a differentiated tumor cell phenotype and inhibits pancreatic cancer metastasis.
Ostapoff KT; Cenik BK; Wang M; Ye R; Xu X; Nugent D; Hagopian MM; Topalovski M; Rivera LB; Carroll KD; Brekken RA
Cancer Res; 2014 Sep; 74(18):4996-5007. PubMed ID: 25060520
[TBL] [Abstract][Full Text] [Related]
14. TGF-β signaling pathway: Therapeutic targeting and potential for anti-cancer immunity.
Ali S; Rehman MU; Yatoo AM; Arafah A; Khan A; Rashid S; Majid S; Ali A; Ali MN
Eur J Pharmacol; 2023 May; 947():175678. PubMed ID: 36990262
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta signaling in prostate stromal cells supports prostate carcinoma growth by up-regulating stromal genes related to tissue remodeling.
Verona EV; Elkahloun AG; Yang J; Bandyopadhyay A; Yeh IT; Sun LZ
Cancer Res; 2007 Jun; 67(12):5737-46. PubMed ID: 17575140
[TBL] [Abstract][Full Text] [Related]
16. TGFβ: A player on multiple fronts in the tumor microenvironment.
Caja F; Vannucci L
J Immunotoxicol; 2015; 12(3):300-7. PubMed ID: 25140864
[TBL] [Abstract][Full Text] [Related]
17. T cell receptor (TCR)-transgenic CD8 lymphocytes rendered insensitive to transforming growth factor beta (TGFβ) signaling mediate superior tumor regression in an animal model of adoptive cell therapy.
Quatromoni JG; Wang Y; Vo DD; Morris LF; Jazirehi AR; McBride W; Chatila T; Koya RC; Economou JS
J Transl Med; 2012 Jun; 10():127. PubMed ID: 22713761
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneous Stromal Signaling within the Tumor Microenvironment Controls the Metastasis of Pancreatic Cancer.
Rucki AA; Foley K; Zhang P; Xiao Q; Kleponis J; Wu AA; Sharma R; Mo G; Liu A; Van Eyk J; Jaffee EM; Zheng L
Cancer Res; 2017 Jan; 77(1):41-52. PubMed ID: 27821486
[TBL] [Abstract][Full Text] [Related]
19. IKKβ acts as a tumor suppressor in cancer-associated fibroblasts during intestinal tumorigenesis.
Pallangyo CK; Ziegler PK; Greten FR
J Exp Med; 2015 Dec; 212(13):2253-66. PubMed ID: 26621452
[TBL] [Abstract][Full Text] [Related]
20. The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis.
Avouac J; Palumbo-Zerr K; Ruzehaji N; Tomcik M; Zerr P; Dees C; Distler A; Beyer C; Schneider H; Distler O; Schett G; Allanore Y; Distler JH
Arthritis Rheumatol; 2014 Nov; 66(11):3140-50. PubMed ID: 25155144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
